Table 2.
WT-CON | GULO-CON | GULO-SCV | ANOVA F value | |
---|---|---|---|---|
Cortex | ||||
Dopamine | 14.88 ± 3.60 | 22.56 ± 4.64 | 8.69 ± 3.08 | F =3.29, p=0.057 |
DOPAC | 3.87 ± 0.61c | 4.00 ± 0.63c | 1.45 ± 0.32d | F =7.07, p<0.01 |
HVA | 3.81 ± 0.44a | 4.43 ± 0.51a | 2.34 ± 0.38b | F =5.73, p<0.01 |
3-MT | 2.36 ± 0.37a | 2.99 ± 0.56a | 0.95 ± 0.24b | F =6.34, p<0.01 |
Norepinephrine | 4.47 ± 0.23 | 4.79 ± 0.30 | 4.71 ± 0.27 | F =0.39, p=0.68 |
Serotonin | 4.51 ± 0.39 | 5.29 ± 0.37 | 5.39 ± 0.47 | F =1.36, p=0.28 |
5-HIAA | 4.38 ± 0.37e | 4.18 ± 0.34e | 2.40 ± 0.18f | F =12.62, p<0.001 |
Striatum | ||||
Dopamine | 95.88 ± 12.90 | 130.16 ± 17.91 | 118.64 ± 14.81 | F =1.29, p=0.30 |
DOPAC | 12.87 ± 1.88 | 12.62 ± 1.85 | 8.15 ± 0.78 | F =2.80, p=0.083 |
HVA | 13.80 ± 1.27 | 16.51 ± 1.94 | 12.39 ± 1.04 | F =2.033, p=0.16 |
3-MT | 11.63 ± 1.73 | 14.23 ± 1.74 | 11.40 ± 1.38 | F =0.94, p=0.41 |
Norepinephrine | 2.92 ± 0.41 | 4.25 ± 0.67 | 3.08 ± 0.37 | F =2.093, p=0.15 |
Serotonin | 8.08 ± 0.43a | 10.41 ± 0.88b | 7.63 ± 0.56a | F =5.29, p<0.05 |
5-HIAA | 6.45 ± 0.52c | 7.52 ± 0.48c | 4.20 ± 0.33d | F =14.03, p<0.001 |
Data reported are group mean ± S.E.M. F values refer to results of initial omnibus analysis of data. Columns with different subscripts show differences between specific groups as revealed in follow-up comparisons
p<0.05;
p<0.01.